Skip to main content
Erschienen in: Journal of Neural Transmission 12/2008

01.12.2008 | Alzheimer's Disease and Related Disorders - Original Article

Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy

verfasst von: Julian R. Thorpe, Helen Tang, Joe Atherton, Nigel J. Cairns

Erschienen in: Journal of Neural Transmission | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

TAR DNA-binding protein of 43 kDa (TDP-43) is a major component of the pathological inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy, also called FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U), and motor neuron disease (MND). TDP-43 is predominantly expressed in the nucleus and regulates gene expression and splicing. In FTLD with TDP-43 proteinopathy, neuronal inclusions present variably as cytoplasmic inclusions (NCIs), dystrophic neurites (DNs), and intranuclear inclusions (NIIs), leading to a fourfold neuropathological classification correlating with genotype. There have been few fine structural studies of these inclusions. Thus, we undertook an immunoelectron microscopic study of FTLD with TDP-43 proteinopathy, including sporadic and familial cases with progranulin (GRN) mutation. TDP-43-immunoreactive inclusions comprised two components: granular and filamentous. Filament widths, expressed as mean (range) were: NCI, 9 nm (4–16 nm); DN, 10 nm (5–16 nm); NII, 18 nm (9–50 nm). Morphologically distinct inclusion components may reflect the process of TDP-43 aggregation and interaction with other proteins: determining these latter may contribute towards understanding the heterogeneous pathogenesis of FTLD with TDP-43 proteinopathy.
Literatur
Zurück zum Zitat Amador-Ortiz CLW, Ahmed Z, Personett D et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445PubMedCrossRef Amador-Ortiz CLW, Ahmed Z, Personett D et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445PubMedCrossRef
Zurück zum Zitat Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611PubMedCrossRef Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611PubMedCrossRef
Zurück zum Zitat Armstrong RAL, Lantos PL, Cairns NJ (2008) What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology PM:18433435 Armstrong RAL, Lantos PL, Cairns NJ (2008) What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology PM:18433435
Zurück zum Zitat Ayala YM, Pantano S, D’Ambrogio A et al (2005) Human, Drosophila, and C elegans TDP 43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348:575–588PubMedCrossRef Ayala YM, Pantano S, D’Ambrogio A et al (2005) Human, Drosophila, and C elegans TDP 43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348:575–588PubMedCrossRef
Zurück zum Zitat Brandmeir NJ, Geser F, Kwong LK et al (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123–131PubMedCrossRef Brandmeir NJ, Geser F, Kwong LK et al (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123–131PubMedCrossRef
Zurück zum Zitat Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276:36337–36343PubMedCrossRef Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276:36337–36343PubMedCrossRef
Zurück zum Zitat Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20:1774–1784PubMedCrossRef Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20:1774–1784PubMedCrossRef
Zurück zum Zitat Buratti E, Brindisi A, Pagani F, Baralle FE (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of Exon 9: a functional link with disease penetrance. Am J Hum Genet 74:1322–1325PubMedCrossRef Buratti E, Brindisi A, Pagani F, Baralle FE (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of Exon 9: a functional link with disease penetrance. Am J Hum Genet 74:1322–1325PubMedCrossRef
Zurück zum Zitat Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail—An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280:37572–37584PubMedCrossRef Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail—An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280:37572–37584PubMedCrossRef
Zurück zum Zitat Cairns NJ, Bigio EH, Mackenzie IRA et al (2007a) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22PubMedCrossRef Cairns NJ, Bigio EH, Mackenzie IRA et al (2007a) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22PubMedCrossRef
Zurück zum Zitat Cairns NJ, Neumann M, Bigio EH et al (2007b) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171:227–240PubMedCrossRef Cairns NJ, Neumann M, Bigio EH et al (2007b) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171:227–240PubMedCrossRef
Zurück zum Zitat Davidson Y, Kelley T, Mackenzie IRA et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533PubMedCrossRef Davidson Y, Kelley T, Mackenzie IRA et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533PubMedCrossRef
Zurück zum Zitat Geser F, Winton MJ, Kwong LK et al (2008) Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115:133–145PubMedCrossRef Geser F, Winton MJ, Kwong LK et al (2008) Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 115:133–145PubMedCrossRef
Zurück zum Zitat Gitcho MA, Baloh RH, Chakraverty S et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538PubMedCrossRef Gitcho MA, Baloh RH, Chakraverty S et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535–538PubMedCrossRef
Zurück zum Zitat Hasegawa MAT, Nonaka T, Kametani F et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60–70PubMedCrossRef Hasegawa MAT, Nonaka T, Kametani F et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60–70PubMedCrossRef
Zurück zum Zitat Higashi S, Iseki E, Yamamoto R et al (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 1184:284–294PubMedCrossRef Higashi S, Iseki E, Yamamoto R et al (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 1184:284–294PubMedCrossRef
Zurück zum Zitat Ignatius SH, Wu F, Harrich D, Garciamartinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human-immunodeficiency-virus type-1 Tar DNA-sequence motifs. J Virol 69:3584–3596 Ignatius SH, Wu F, Harrich D, Garciamartinez LF, Gaynor RB (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human-immunodeficiency-virus type-1 Tar DNA-sequence motifs. J Virol 69:3584–3596
Zurück zum Zitat Johnson BS, McCaffery JM, Lindquist S, Gitler AD (2008) A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDR-43 aggregation and cellular toxicity. Proc Natl Acad Sci USA 105:6439–6444PubMedCrossRef Johnson BS, McCaffery JM, Lindquist S, Gitler AD (2008) A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDR-43 aggregation and cellular toxicity. Proc Natl Acad Sci USA 105:6439–6444PubMedCrossRef
Zurück zum Zitat Kabashi E, Valdmanis PN, Dion P et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574PubMedCrossRef Kabashi E, Valdmanis PN, Dion P et al (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572–574PubMedCrossRef
Zurück zum Zitat Lin W-L, Dickson DW (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 116:205–213PubMedCrossRef Lin W-L, Dickson DW (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 116:205–213PubMedCrossRef
Zurück zum Zitat Mosaheb S, Thorpe JR, Hashemzadeh-Bonehi L, Bigio EH, Gearing M, Cairns NJ (2005) Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease. Acta Neuropathol 110:360–368PubMedCrossRef Mosaheb S, Thorpe JR, Hashemzadeh-Bonehi L, Bigio EH, Gearing M, Cairns NJ (2005) Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease. Acta Neuropathol 110:360–368PubMedCrossRef
Zurück zum Zitat Mukherjee OP, Pastor P, Cairns NJ et al (2006) HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 60:314–322PubMedCrossRef Mukherjee OP, Pastor P, Cairns NJ et al (2006) HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 60:314–322PubMedCrossRef
Zurück zum Zitat Mukherjee O, Wang J, Gitcho M et al (2008) Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum Mutat 29:512–521PubMedCrossRef Mukherjee O, Wang J, Gitcho M et al (2008) Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum Mutat 29:512–521PubMedCrossRef
Zurück zum Zitat Nakashima-Yasuda H, Uryu K, Robinson J et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221–229PubMedCrossRef Nakashima-Yasuda H, Uryu K, Robinson J et al (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221–229PubMedCrossRef
Zurück zum Zitat Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133PubMedCrossRef
Zurück zum Zitat Seelaar H, Schelhaas HJ, Azmani A et al (2007) TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations. Brain 130:1375–1385PubMedCrossRef Seelaar H, Schelhaas HJ, Azmani A et al (2007) TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations. Brain 130:1375–1385PubMedCrossRef
Zurück zum Zitat Sreedharan J, Blair IP, Tripathi VB et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672PubMedCrossRef Sreedharan J, Blair IP, Tripathi VB et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672PubMedCrossRef
Zurück zum Zitat Thorpe JR (1999) The application of LR gold resin for immunogold labelling. Chapter 6 In: MA Hajibagheri (ed) Electron microscopy methods and protocols. Methods in molecular biology Series, vol 117. pp 99–110 Thorpe JR (1999) The application of LR gold resin for immunogold labelling. Chapter 6 In: MA Hajibagheri (ed) Electron microscopy methods and protocols. Methods in molecular biology Series, vol 117. pp 99–110
Zurück zum Zitat Thorpe JR, Morley SJ, Rulten SL (2001) Utilising the peptidyl- prolyl cis-trans isomerase Pin1 as a probe of its phosphorylated target proteins: examples of binding to nuclear proteins in a human kidney cell line and to Tau in Alzheimer’s diseased brain. J Histochem Cytochem 49:97–108PubMed Thorpe JR, Morley SJ, Rulten SL (2001) Utilising the peptidyl- prolyl cis-trans isomerase Pin1 as a probe of its phosphorylated target proteins: examples of binding to nuclear proteins in a human kidney cell line and to Tau in Alzheimer’s diseased brain. J Histochem Cytochem 49:97–108PubMed
Zurück zum Zitat Thorpe JR, Mosaheb S, Hashemzadeh-Bonehi L et al (2004) Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias. Neurobiol Dis 17:237–249PubMedCrossRef Thorpe JR, Mosaheb S, Hashemzadeh-Bonehi L et al (2004) Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias. Neurobiol Dis 17:237–249PubMedCrossRef
Zurück zum Zitat Uryu KN-Y, Forman H, Kwong MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropath Exp Neurol 67:555–564PubMedCrossRef Uryu KN-Y, Forman H, Kwong MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropath Exp Neurol 67:555–564PubMedCrossRef
Zurück zum Zitat Zuccato E, Buratti E, Stuani C, Baralle FE, Pagani F (2004) An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem 279:16980–16988PubMedCrossRef Zuccato E, Buratti E, Stuani C, Baralle FE, Pagani F (2004) An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem 279:16980–16988PubMedCrossRef
Metadaten
Titel
Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy
verfasst von
Julian R. Thorpe
Helen Tang
Joe Atherton
Nigel J. Cairns
Publikationsdatum
01.12.2008
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 12/2008
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-008-0137-1

Weitere Artikel der Ausgabe 12/2008

Journal of Neural Transmission 12/2008 Zur Ausgabe

Basic Neurosciences, Genetics and Immunology - Original Article

Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.